A detailed history of Quest Partners LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 4 shares of CRL stock, worth $744. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 5,411 99.93%
Holding current value
$744
Previous $1.12 Billion 99.93%
% of portfolio
0.0%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$187.96 - $245.29 $1.02 Million - $1.33 Million
-5,407 Reduced 99.93%
4 $788,000
Q2 2024

Aug 06, 2024

BUY
$206.39 - $268.73 $1.12 Million - $1.45 Million
5,407 Added 135175.0%
5,411 $1.12 Billion
Q1 2024

May 09, 2024

BUY
$203.52 - $273.43 $814 - $1,093
4 New
4 $1.08 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.47B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.